Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC2351270759;70760;70761 chr2:178575598;178575597;178575596chr2:179440325;179440324;179440323
N2AB2187165836;65837;65838 chr2:178575598;178575597;178575596chr2:179440325;179440324;179440323
N2A2094463055;63056;63057 chr2:178575598;178575597;178575596chr2:179440325;179440324;179440323
N2B1444743564;43565;43566 chr2:178575598;178575597;178575596chr2:179440325;179440324;179440323
Novex-11457243939;43940;43941 chr2:178575598;178575597;178575596chr2:179440325;179440324;179440323
Novex-21463944140;44141;44142 chr2:178575598;178575597;178575596chr2:179440325;179440324;179440323
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: E
  • RefSeq wild type transcript codon: GAG
  • RefSeq wild type template codon: CTC
  • Domain: Fn3-58
  • Domain position: 78
  • Structural Position: 111
  • Q(SASA): 0.2266
  • Predicted PPI site: I

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
E/D None None 0.974 N 0.459 0.342 0.335910606209 gnomAD-4.0.0 1.20032E-06 None None None None I None 0 0 None 0 0 None 0 0 0 6.07533E-05 0
E/G None None 1.0 N 0.765 0.585 0.459906663326 gnomAD-4.0.0 1.59157E-06 None None None None I None 0 0 None 0 0 None 0 0 2.85914E-06 0 0
E/K rs752696466 -0.669 0.998 N 0.538 0.388 0.315609569513 gnomAD-2.1.1 4.02E-06 None None None None I None 0 0 None 0 0 None 3.27E-05 None 0 0 0
E/K rs752696466 -0.669 0.998 N 0.538 0.388 0.315609569513 gnomAD-4.0.0 1.59154E-06 None None None None I None 0 0 None 0 0 None 0 0 0 1.43299E-05 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
E/A 0.5104 ambiguous 0.5779 pathogenic -0.633 Destabilizing 0.997 D 0.677 prob.neutral N 0.481520094 None None I
E/C 0.9267 likely_pathogenic 0.9445 pathogenic -0.429 Destabilizing 1.0 D 0.853 deleterious None None None None I
E/D 0.9006 likely_pathogenic 0.9221 pathogenic -1.366 Destabilizing 0.974 D 0.459 neutral N 0.521566946 None None I
E/F 0.9735 likely_pathogenic 0.9832 pathogenic -0.957 Destabilizing 1.0 D 0.881 deleterious None None None None I
E/G 0.7537 likely_pathogenic 0.8233 pathogenic -0.941 Destabilizing 1.0 D 0.765 deleterious N 0.510046057 None None I
E/H 0.934 likely_pathogenic 0.9522 pathogenic -1.212 Destabilizing 1.0 D 0.687 prob.neutral None None None None I
E/I 0.636 likely_pathogenic 0.7022 pathogenic 0.183 Stabilizing 0.999 D 0.887 deleterious None None None None I
E/K 0.5762 likely_pathogenic 0.671 pathogenic -0.536 Destabilizing 0.998 D 0.538 neutral N 0.479571538 None None I
E/L 0.872 likely_pathogenic 0.9135 pathogenic 0.183 Stabilizing 0.999 D 0.861 deleterious None None None None I
E/M 0.7441 likely_pathogenic 0.8045 pathogenic 0.664 Stabilizing 0.999 D 0.835 deleterious None None None None I
E/N 0.9178 likely_pathogenic 0.9367 pathogenic -0.819 Destabilizing 0.998 D 0.737 prob.delet. None None None None I
E/P 0.9988 likely_pathogenic 0.9992 pathogenic -0.067 Destabilizing 0.994 D 0.83 deleterious None None None None I
E/Q 0.2891 likely_benign 0.3396 benign -0.72 Destabilizing 0.999 D 0.62 neutral N 0.484571514 None None I
E/R 0.7336 likely_pathogenic 0.7975 pathogenic -0.579 Destabilizing 1.0 D 0.738 prob.delet. None None None None I
E/S 0.6694 likely_pathogenic 0.7252 pathogenic -1.181 Destabilizing 0.997 D 0.597 neutral None None None None I
E/T 0.6763 likely_pathogenic 0.7358 pathogenic -0.908 Destabilizing 0.999 D 0.815 deleterious None None None None I
E/V 0.3434 ambiguous 0.4062 ambiguous -0.067 Destabilizing 0.998 D 0.829 deleterious N 0.448303854 None None I
E/W 0.995 likely_pathogenic 0.9966 pathogenic -1.071 Destabilizing 1.0 D 0.856 deleterious None None None None I
E/Y 0.9724 likely_pathogenic 0.9807 pathogenic -0.755 Destabilizing 1.0 D 0.85 deleterious None None None None I

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.